Skip to main content
. 2020 Nov 12;8:e10335. doi: 10.7717/peerj.10335

Table 1. Clinical parameters of the DLBCL patients study group (n = 280).

Parameter Frequency
Age
<70 years 107 (38.2%)
M 70 years 173 (61.8%)
Sex
M 148 (52.9%)
F 132 (47.1%)
ECOG score
0+1 169 (60.4%)
2-3 111 (39.6%)
B-symptoms
No 113 (40.4%)
Yes 167 (59.6%)
IPI score
0–2 107 (38.2%)
3–5 173 (61.8%)
Stage
I–II 42 (15.0%)
III–IV 238 (85.0%)
Extranodal involvement
No 145 (51.8%)
Yes 135 (48.2%)
Leukemization
No 199 (71.1%)
Yes 81 (28.9%)
LDH level
Normal 153 (54.6%)
Elevated 127 (45.4%)

Note:

ECOG, Eastern Cooperative Oncology Group; IPI, International Prognostic Index; LDH, Lactate dehydrogenase.